- Report
- August 2022
- 243 Pages
Global
From €2336EUR$2,500USD£1,976GBP
- Report
- April 2022
- 330 Pages
Global
From €2336EUR$2,500USD£1,976GBP
- Report
- October 2024
Global
From €3270EUR$3,500USD£2,766GBP
- Report
- March 2024
- 132 Pages
Global
From €888EUR$950USD£751GBP
- Report
- July 2024
- 280 Pages
Global
From €2480EUR$2,655USD£2,098GBP
- Report
- December 2022
- 375 Pages
Global
From €3335EUR$3,570USD£2,821GBP
- Book
- April 2019
- 400 Pages
- Book
- July 2018
- 832 Pages
- Book
- March 2015
- 512 Pages
- Book
- February 2012
- 648 Pages
- Book
- June 2009
- 1000 Pages
- Book
- May 2021
- 1488 Pages
Global
- Book
- May 2021
- 1488 Pages
Global
- Book
- February 2020
- 1152 Pages
- Book
- August 2022
North America

The Lipoprotein market is a subset of the biotechnology industry that focuses on the development of drugs and treatments related to lipoproteins. Lipoproteins are molecules composed of proteins and lipids that are responsible for transporting cholesterol and other lipids throughout the body. Lipoproteins are essential for maintaining healthy cholesterol levels and are involved in many metabolic processes.
The Lipoprotein market is driven by the increasing prevalence of cardiovascular diseases, such as atherosclerosis, and the need for effective treatments. Additionally, the development of new technologies and the increasing availability of data are driving the growth of the Lipoprotein market.
Some of the major companies in the Lipoprotein market include Amgen, AstraZeneca, Merck, Pfizer, and Sanofi. These companies are involved in the development of drugs and treatments related to lipoproteins, as well as the research and development of new technologies. Show Less Read more